Ralph N. Adams Award
The 2011 Ralph N. Adams Award in Bioanalytical Chemistry will be presented to James W. Jorgenson, the William Rand Kenan, Jr., Distinguished Professor of Chemistry at the University of North Carolina at Chapel Hill, on Wednesday afternoon at Pittcon 2011.
Wednesday, March 16, 2011
2:00 p.m. Room 312
The 2011 Ralph N. Adams Award in Bioanalytical Chemistry will be presented to James W. Jorgenson, the William Rand Kenan, Jr., Distinguished Professor of Chemistry at the University of North Carolina at Chapel Hill, on Wednesday afternoon at Pittcon 2011. The award is sponsored jointly by the Pittsburgh Conference and Friends of Ralph N. Adams. Jorgenson will receive the award from Annette S. Wilson, the Immediate Former President of the Pittsburgh Conference. The award recognizes outstanding scientists who have advanced the field of bioanalytical chemistry through research, innovation, and education. Jorgenson will be honored for his leadership in the development of separation methods widely used in bioanalytical chemistry. The award presentation will be followed by a session of oral presentations on the LC–MS analysis of complex protein mixtures, glycoscience, microfabricated chemical instrumentation, analysis of attoliter transmitter vesicles, and segmented flow microfluidics.
Jorgenson, who has been at the University of North Carolina at Chapel Hill since 1979, was a leader in the development of capillary electrophoresis for microscale chemical separations, including the possibility of analyzing the contents of single biological cells. Recently he has studied microbore liquid chromatography at ultrahigh pressures.
Jorgenson has received a number of awards for his efforts, including the American Chemical Society Award in Analytical Chemistry, the Pittsburgh Analytical Chemistry Award, and the American Chemical Society Award in Chromatography. In 2007, he was elected a member of the American Academy of Arts and Sciences, and from 2000 to 2005 he was the Chemistry Department Chair at the University of North Carolina, Chapel Hill. Jorgenson is also the 2011 recipient of the LCGC Lifetime Achievement award.
New TRC Facility Accelerates Innovation and Delivery
April 25th 2025We’ve expanded our capabilities with a state-of-the-art, 200,000 sq ft TRC facility in Toronto, completed in 2024 and staffed by over 100 PhD- and MSc-level scientists. This investment enables the development of more innovative compounds, a broader catalogue and custom offering, and streamlined operations for faster delivery. • Our extensive range of over 100,000 high-quality research chemicals—including APIs, metabolites, and impurities in both native and stable isotope-labelled forms—provides essential tools for uncovering molecular disease mechanisms and exploring new opportunities for therapeutic intervention.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.
